In recent years, the clinical presentation of breast cancer has evolved over the course of its growth and this fact has contributed to the need for new imaging techniques. Molecular imaging and the use of various radiolabeling compounds in order to demonstrate and describe it in everyday practice are a novel feature. The clinical aspects that we feel are of greatest concern are reviewed in this paper.
Author (s) Details
IDIS, Complejo Hospitalario Universitario, Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain.
José María Benlloch
Instituto de Instrumentacio´n Para Imagen Molecular, Universidad Polit´ecnica de Valencia (UPV) and Consejo Superior de Investigaciones Cient´ıficas (CSIC), 46022 Val`encia, Spain.
Renato Valdés Olmos
Nuclear Medicine Department, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.
Physical Organic Chemistry, Department of Chemistry (BMC), Uppsala University, 75123 Uppsala, Sweden.
View Book :- https://stm.bookpi.org/CTMMR-V12/issue/view/10